Biomm

Risk score

57
Large logo of Biomm

Headquarters

Flag of BrazilBrazil

Biomm originated with the objective of developing, producing, and marketing biopharmaceuticals with global competitiveness, quality, and accessibility, delivering superior treatments to an expanding populace. Established in 2001, as part of a division from a prominent international insulin producer, Biomm stands as the initial and singular Brazilian enterprise entirely dedicated to biotechnology. Our manufacturing facility is situated in Nova Lima, within the metropolitan vicinity of Belo Horizonte (MG), and is fully outfitted with cutting-edge biopharmaceutical production technology.